Title |
Virgin Coconut Oil and Its Potential Cardioprotective Effects
|
---|---|
Published in |
Postgraduate Medicine, March 2015
|
DOI | 10.3810/pgm.2014.11.2835 |
Pubmed ID | |
Authors |
Abraham Samuel Babu, Sundar Kumar Veluswamy, Ross Arena, Marco Guazzi, Carl J. Lavie |
Abstract |
Emphasis on diet to improve the cardiovascular (CV) risk profile has been the focus of many studies. Recently, virgin coconut oil (VCO) has been growing in popularity due to its potential CV benefits. The chemical properties and the manufacturing process of VCO make this oil healthier than its copra-derived counterpart. This review highlights the mechanism through which saturated fatty acids contribute to CV disease (CVD), how oils and fats contribute to the risk of CVD, and the existing views on VCO and how its cardioprotective effects may make this a possible dietary intervention in isolation or in combination with exercise to help reduce the burden of CVDs. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 24% |
Spain | 3 | 18% |
Venezuela, Bolivarian Republic of | 1 | 6% |
Argentina | 1 | 6% |
Chile | 1 | 6% |
Brazil | 1 | 6% |
Unknown | 6 | 35% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 11 | 65% |
Practitioners (doctors, other healthcare professionals) | 4 | 24% |
Science communicators (journalists, bloggers, editors) | 1 | 6% |
Unknown | 1 | 6% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Israel | 1 | <1% |
United States | 1 | <1% |
China | 1 | <1% |
Unknown | 269 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 52 | 19% |
Student > Master | 45 | 17% |
Researcher | 21 | 8% |
Student > Ph. D. Student | 14 | 5% |
Student > Postgraduate | 12 | 4% |
Other | 46 | 17% |
Unknown | 82 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 44 | 16% |
Agricultural and Biological Sciences | 44 | 16% |
Nursing and Health Professions | 29 | 11% |
Biochemistry, Genetics and Molecular Biology | 14 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 12 | 4% |
Other | 37 | 14% |
Unknown | 92 | 34% |